Nadine T. Hillock

Value assessment of antimicrobials and the implications for development, access, and funding of effective treatments: Australian stakeholder perspective

J. Karnon, J. Turnidge, T. Merlin, 2020, International Journal of Technology Assessment in Health Care.

Feasibility of de-linking reimbursement of antimicrobials from sales: the Australian perspective as a qualitative case study

J. Karnon, J. Turnidge, T. Merlin, 2020, JAC-antimicrobial resistance.

South Australian Medicines Evaluation Panel in review: providing evidence-based guidance on the use of high-cost medicines in the South Australian public health system.

T. Merlin, P. Hissaria, M. Ward, 2021, Australian health review : a publication of the Australian Hospital Association.

Modelling the Future Clinical and Economic Burden of Antimicrobial Resistance: The Feasibility and Value of Models to Inform Policy

J. Karnon, J. Turnidge, Nadine T. Hillock, 2022, Applied Health Economics and Health Policy.

Infliximab for ipilimumab‐induced colitis: A series of 13 patients

J. Andrews, C. Hill, G. Kichenadasse, 2017, Asia-Pacific journal of clinical oncology.